Wootton, M., Walsh, Timothy Rutland ![]() |
Abstract
Objectives To assess the activity of mecillinam against two groups of Escherichia coli: (i) a selection of international isolates with mechanisms of resistance caused by the presence of defined β-lactamases; and (ii) isolates resistant to third-generation cephalosporins referred from across Wales. Methods Antibiotic susceptibility testing with mecillinam, meropenem, amoxicillin, co-amoxiclav, cefotaxime, piperacillin/tazobactam, ciprofloxacin, nitrofurantoin, trimethoprim and gentamicin was performed using the BSAC agar dilution method against 30 international strains of E. coli with known β-lactamase presence. Antibiotic susceptibility testing with mecillinam using the same method was performed against 325 regional isolates of E. coli resistant to third-generation cephalosporins. Results The susceptibility results showed that the only antibiotics to which the 30 international isolates were consistently susceptible were mecillinam (100%) and meropenem (100%), irrespective of the presence of β-lactamases. Of the local isolates, 93.5% (304/325) were susceptible to mecillinam, having MICs < 8 mg/L. Conclusions Our results show that mecillinam has excellent in vitro activity against a range of E. coli exhibiting β-lactamase activity, some with the production of multiple β-lactamases. It is time to further evaluate the clinical utility of mecillinam in the treatment of infections caused by such organisms.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine Systems Immunity Research Institute (SIURI) |
Subjects: | Q Science > QR Microbiology > QR180 Immunology |
Uncontrolled Keywords: | ESBLs, susceptibilities, resistance |
Publisher: | Oxford University Press |
ISSN: | 0305-7453 |
Last Modified: | 20 Oct 2022 07:54 |
URI: | https://orca.cardiff.ac.uk/id/eprint/26865 |
Citation Data
Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |